Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression
Clinical trial NCT03965871 · COMPLETED
Trial details
- NCT number
- NCT03965871
- Sponsor
- Celon Pharma SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2021-01-03
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.